Globe Life (NYSE: GL) director reports 1,373-share grant update filing
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
Globe Life Inc. director Matthew J. Adams filed an amended insider report after acquiring additional company stock. On January 2, 2026, he acquired 1,373 shares of Globe Life common stock at a reported price of $0 per share, increasing his direct holdings.
Following this transaction, Adams now beneficially owns 2,558.3971 Globe Life shares directly and holds no shares indirectly. The amendment clarifies that this total was corrected to include 2.3971 shares previously acquired through the company’s dividend reinvestment plan, while noting that the original filing was submitted on time.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Adams Matthew J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,373 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,558.397 shares (Direct);
Common Stock — 0 shares (Indirect, Not Applicable)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Globe Life (GL) report for Matthew J. Adams?
Matthew J. Adams, a director of Globe Life Inc., reported acquiring 1,373 shares of Globe Life common stock on January 2, 2026 at a reported price of $0 per share.
Why was this Globe Life (GL) Form 4 filing amended?
The filing was amended to correct the amount of securities beneficially owned, adding 2.3971 shares that were acquired through the company’s dividend reinvestment plan since the last report.
What role does Matthew J. Adams hold at Globe Life (GL)?
Matthew J. Adams is identified in the filing as a director of Globe Life Inc.